Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Rapid Detection of SARS-CoV-2 Virus Via Novel Direct Amplification Methods

Part # GPN058


Dana Brecklin1, Jennifer Mook1, Brad Hook1, PhD, Curtis Knox1, Terri McDonnell1, Rod Pennington1, PhD
1Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711

The COVID-19 pandemic has challenged clinical labs to explore ways to increase testing capacity in response to unprecedented demand. This has created a global shortage of viral RNA extraction kits, necessitating the search for alternative methods to meet testing needs. Here, we describe a novel set of reagents and protocols to support rapid viral testing via direct amplification without the need for viral RNA extraction.

Printed in USA.